Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people ...
March 11, 2026 – New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has demonstrated that OGM provided reliable and robust analytical ...
Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...
New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...
In this Teach Me in 10 episode, Dr. Shaveta Goyal, Group Leader of NGS at Takara Bio USA, outlines the practical ...
Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this ...
AGBT is also, increasingly, a showcase for instruments for spatial biology, a fast-growing field that involves pinpointing ...
New automation scripts integrate sequencing sample preparation and amplification with liquid handling systems, enabling ...
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing (NGS) assay for genetic analysis of thalassemia and sickle cell disease (SCD) available on the Europ ...
Pillar Biosciences today announced the launch of the oncoReveal ® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate ...
Reflecting on the strength of the community and engagement, Dr. Chaubey said, “Symposium 2026 is a living example of turning possibility into reality – a community united by the desire to be among the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results